Novel leptomycins from a streptomyces strain A92‐308902: Inhibitors of the Nucleo‐cytoplasmic translocation of the HIV‐1 regulatory protein Rev

This publication has 38 references indexed in Scilit:

• Nucleocytoplasmic Transport of the Rev Protein of Human Immunodeficiency Virus Type 1 Is Dependent on the Activation Domain of the Protein
  Experimental Cell Research, 1995
• The HIV-1 Rev trans-activator shuttles between the nucleus and the cytoplasm.
  Genes & Development, 1994
• The inhibition of C5a receptor binding by analogs of L-156,602, a cyclic hexadepsipeptide antibiotic
  Bioorganic & Medicinal Chemistry Letters, 1992
• Preferential Suppression of Delayed-type Hypersensitivity by L-156,602, a C5a Receptor Antagonist
  Bioscience, Biotechnology, and Biochemistry, 1992
• New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
  JNCI Journal of the National Cancer Institute, 1990
• Synthesis of the lipophilic side chain of the cyclic hexadepsipeptide antibiotic L-156,602
  The Journal of Organic Chemistry, 1990
• Effects of leptomycin B on the cell cycle of fibroblasts and fission yeast cells
  Experimental Cell Research, 1990
• The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA
  Nature, 1989
• Trans -Activator Gene of Human T-Lymphotropic Virus Type III (HTLV-III)
  Science, 1985
• Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS
  Science, 1984